EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Right orbitofrontal cortex rTMS targets anxiety, not depressive, symptoms in first-episode schizophrenia

YiYi Yang, Qiang Hu, Xiong Jiao, YanYan Wei, HuiRu Cui, XiaoChen Tang, LiHua Xu, YingYing Tang, HaiChun Liu, Jin Gao, LingYun Zeng, ChunBo Li und 2 weitere

Journal of Affective Disorders · 2026

DOI: 10.1016/j.jad.2026.121300 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Affective Disorders, 2026. Verfasst von YiYi Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Neuromodulation Center, Shanghai Engineering Research Center of Intel…. Hauptthemen laut MEDLINE: Schizophrenia, Transcranial Magnetic Stimulation, Prefrontal Cortex, Anxiety. Die Arbeit nennt 42 Literaturangaben. Gefördert von: Nantong Municipal Science and Technology Bureau, Ministry of Science and Technology of the People's Republic of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Anxiety is highly prevalent and undertreated in first-episode schizophrenia(FES), but repetitive transcranial magnetic stimulation(rTMS) data for this comorbidity are scarce. The orbitofrontal cortex(OFC) is a key anxiety-regulating node, supporting its potential as a target. This study aimed to explore 1-Hz right OFC-rTMS's symptom-specific effects on FES mood. METHODS: This is a secondary analysis of a randomized controlled trial. Participants were drug-naive FES patients randomized to the active rTMS group(n = 51) or sham group(n = 45). All completed 20 intervention sessions, 20 sessions of active OFC-rTMS or sham, with 4-week follow-up, initiating oral olanzapine(10-20 mg/day) concurrently with the first rTMS session. Mood symptoms were assessed using the 24-item Hamilton Depression Rating Scale(HAMD) and the 14-item Hamilton Anxiety Rating Scale(HAMA). Psychopathological symptoms were assessed using the Positive and Negative Syndrome Scale(PANSS). The main outcome was the changes in HAMD and HAMA scores from baseline to 2 weeks and 4 weeks. RESULTS: The active group showed greater PANSS total(t = -3.260, p = 0.002; Cohen's d = 0.672) and subscale improvements vs. the sham group. Repeated-measures ANOVA(controlling for covariates) revealed significant Time×Group interactions for HAMA total(F = 4.698, p = 0.010; partial η2 = 0.059) and psychic anxiety(F = 5.735, p = 0.004; partial η2 = 0.072), but not somatic anxiety. For HAMD, only anxiety/somatization(F = 8.397, p = 0.031; partial η2 = 0.099) and cognitive impairment(F = 6.240, p = 0.002; partial η2 = 0.076) showed interactions, with no specific effects on overall depressive symptoms. In the sham group, HAMD anxiety/somatization correlated with all PANSS subscales(r = 0.311-0.477, p 0.05). CONCLUSIONS: Right OFC-rTMS improves FES anxiety (not depression), supporting it as a targeted non-pharmacological option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaTranscranial Magnetic StimulationPrefrontal CortexAnxietyDepressionSchizophrenic PsychologyHumansMaleFemaleAdultOlanzapineAntipsychotic AgentsBenzodiazepinesPsychiatric Status Rating ScalesTreatment OutcomeYoung Adult

Stichwörter der Autor:innen

AnxietyFirst-episode schizophreniaOrbitofrontal cortexrTMS

Substanzen

OlanzapineAntipsychotic AgentsBenzodiazepines

Autor:innen und Institutionen

  • Shanghai Mental Health Center, Shanghai Jiaotong University School of Medicine, Neuromodulation Center, Shanghai Engineering Research Center of Intelligent Psychological Evaluation and Intervention, Shanghai Key Laborat…
  • Department of Automation, Shanghai Jiao Tong University, Shanghai 200240, China.
  • Department of Clinical Psychology, Qilu Hospital (Qingdao), Cheeloo College of Medicine, Shandong University, Qingdao, Shandong, China.
  • Department of Psychiatric Rehabilitation, Shenzhen Kangning Hospital, ShenZhen, GuangDong, China.

Förderung

  • Nantong Municipal Science and Technology Bureau
  • Ministry of Science and Technology of the People's Republic of China
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Shanghai Municipal Health Commission

Zitieren

APA

Yang, Y., Hu, Q., Jiao, X., Wei, Y., Cui, H., Tang, X., Xu, L., Tang, Y., Liu, H., Gao, J., Zeng, L., Li, C., Wang, J., & Zhang, T. (2026). Right orbitofrontal cortex rTMS targets anxiety, not depressive, symptoms in first-episode schizophrenia. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2026.121300

Vancouver

Yang Y, Hu Q, Jiao X, Wei Y, Cui H, Tang X, et al. Right orbitofrontal cortex rTMS targets anxiety, not depressive, symptoms in first-episode schizophrenia. Journal of Affective Disorders. 2026. doi:10.1016/j.jad.2026.121300

BibTeX
@article{Yang2026,
  author = {Yang, YiYi and Hu, Qiang and Jiao, Xiong and Wei, YanYan and Cui, HuiRu and Tang, XiaoChen and Xu, LiHua and Tang, YingYing and Liu, HaiChun and Gao, Jin and Zeng, LingYun and Li, ChunBo and Wang, JiJun and Zhang, TianHong},
  title = {Right orbitofrontal cortex rTMS targets anxiety, not depressive, symptoms in first-episode schizophrenia},
  journal = {Journal of Affective Disorders},
  year = {2026},
  doi = {10.1016/j.jad.2026.121300}
}
Kostenlos starten →